Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle.
Saved in:
| Title: | Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle. |
|---|---|
| Authors: | Johnson EE; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota - Twin Cities, Minneapolis, Minnesota, USA., Reyes TR; Department of Neurology.; Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, and., Chamberlain JS; Department of Neurology.; Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, and.; Department of Biochemistry, University of Washington School of Medicine, Seattle, Washington, USA., Ervasti JM; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota - Twin Cities, Minneapolis, Minnesota, USA., Tasfaout H; Department of Neurology.; Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, and. |
| Source: | JCI insight [JCI Insight] 2025 Nov 27; Vol. 11 (2). Date of Electronic Publication: 2025 Nov 27 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2379-3708 |
|---|---|
| DOI: | 10.1172/jci.insight.197759 |
